

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.63592805 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.63592805 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.28738193 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.28738193 |
| 5 | aromatic amino acid family catabolic process (GO:0009074) | 6.80470407 |
| 6 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.54108659 |
| 7 | indole-containing compound catabolic process (GO:0042436) | 6.09629482 |
| 8 | indolalkylamine catabolic process (GO:0046218) | 6.09629482 |
| 9 | tryptophan catabolic process (GO:0006569) | 6.09629482 |
| 10 | kynurenine metabolic process (GO:0070189) | 6.00132850 |
| 11 | bile acid biosynthetic process (GO:0006699) | 5.87566027 |
| 12 | omega-hydroxylase P450 pathway (GO:0097267) | 5.82613272 |
| 13 | tryptophan metabolic process (GO:0006568) | 5.75829178 |
| 14 | high-density lipoprotein particle remodeling (GO:0034375) | 5.70079085 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.62314602 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.61255430 |
| 17 | urea cycle (GO:0000050) | 5.59293528 |
| 18 | urea metabolic process (GO:0019627) | 5.59293528 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 5.49331732 |
| 20 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.32649986 |
| 21 | protein carboxylation (GO:0018214) | 5.32649986 |
| 22 | regulation of fibrinolysis (GO:0051917) | 5.31182242 |
| 23 | oxidative demethylation (GO:0070989) | 5.23431108 |
| 24 | cysteine metabolic process (GO:0006534) | 5.21281195 |
| 25 | sulfur amino acid catabolic process (GO:0000098) | 5.20184489 |
| 26 | nitrogen cycle metabolic process (GO:0071941) | 5.14119553 |
| 27 | bile acid metabolic process (GO:0008206) | 5.10998575 |
| 28 | serine family amino acid catabolic process (GO:0009071) | 5.07919923 |
| 29 | regulation of cholesterol esterification (GO:0010872) | 5.07656219 |
| 30 | regulation of protein activation cascade (GO:2000257) | 4.99827459 |
| 31 | complement activation, alternative pathway (GO:0006957) | 4.98827505 |
| 32 | aromatic amino acid family metabolic process (GO:0009072) | 4.94775132 |
| 33 | reverse cholesterol transport (GO:0043691) | 4.90884297 |
| 34 | regulation of triglyceride catabolic process (GO:0010896) | 4.86336322 |
| 35 | tyrosine metabolic process (GO:0006570) | 4.84458720 |
| 36 | plasma lipoprotein particle remodeling (GO:0034369) | 4.84244118 |
| 37 | protein-lipid complex remodeling (GO:0034368) | 4.84244118 |
| 38 | macromolecular complex remodeling (GO:0034367) | 4.84244118 |
| 39 | negative regulation of cholesterol transport (GO:0032375) | 4.82187911 |
| 40 | negative regulation of sterol transport (GO:0032372) | 4.82187911 |
| 41 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.78364740 |
| 42 | S-adenosylmethionine metabolic process (GO:0046500) | 4.74043905 |
| 43 | phospholipid efflux (GO:0033700) | 4.69792202 |
| 44 | homocysteine metabolic process (GO:0050667) | 4.67666084 |
| 45 | acylglycerol homeostasis (GO:0055090) | 4.66088176 |
| 46 | triglyceride homeostasis (GO:0070328) | 4.66088176 |
| 47 | alpha-amino acid catabolic process (GO:1901606) | 4.65911809 |
| 48 | regulation of complement activation (GO:0030449) | 4.63678260 |
| 49 | amino-acid betaine metabolic process (GO:0006577) | 4.62445588 |
| 50 | lysine catabolic process (GO:0006554) | 4.56482983 |
| 51 | lysine metabolic process (GO:0006553) | 4.56482983 |
| 52 | cellular ketone body metabolic process (GO:0046950) | 4.52161012 |
| 53 | phenylpropanoid metabolic process (GO:0009698) | 4.51063159 |
| 54 | drug catabolic process (GO:0042737) | 4.43279271 |
| 55 | plasma lipoprotein particle clearance (GO:0034381) | 4.40207461 |
| 56 | imidazole-containing compound metabolic process (GO:0052803) | 4.39483230 |
| 57 | bile acid and bile salt transport (GO:0015721) | 4.39201833 |
| 58 | coenzyme catabolic process (GO:0009109) | 4.38127518 |
| 59 | glycine metabolic process (GO:0006544) | 4.37421372 |
| 60 | indolalkylamine metabolic process (GO:0006586) | 4.33236563 |
| 61 | cellular glucuronidation (GO:0052695) | 4.32101980 |
| 62 | cholesterol efflux (GO:0033344) | 4.31741049 |
| 63 | glutamate metabolic process (GO:0006536) | 4.27021706 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 4.26874426 |
| 65 | amine catabolic process (GO:0009310) | 4.24622336 |
| 66 | cellular biogenic amine catabolic process (GO:0042402) | 4.24622336 |
| 67 | alkaloid metabolic process (GO:0009820) | 4.24075336 |
| 68 | benzene-containing compound metabolic process (GO:0042537) | 4.13522391 |
| 69 | serine family amino acid metabolic process (GO:0009069) | 4.10972669 |
| 70 | low-density lipoprotein particle remodeling (GO:0034374) | 4.07925333 |
| 71 | plasma lipoprotein particle assembly (GO:0034377) | 4.07096874 |
| 72 | arginine metabolic process (GO:0006525) | 4.03228092 |
| 73 | cellular modified amino acid catabolic process (GO:0042219) | 4.03200454 |
| 74 | ethanol oxidation (GO:0006069) | 4.01877106 |
| 75 | aldehyde catabolic process (GO:0046185) | 3.97546272 |
| 76 | regulation of bile acid biosynthetic process (GO:0070857) | 3.97482594 |
| 77 | serine family amino acid biosynthetic process (GO:0009070) | 3.96613772 |
| 78 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.93785823 |
| 79 | fibrinolysis (GO:0042730) | 3.93062445 |
| 80 | ketone body metabolic process (GO:1902224) | 3.91372577 |
| 81 | negative regulation of lipase activity (GO:0060192) | 3.89606268 |
| 82 | exogenous drug catabolic process (GO:0042738) | 3.86315309 |
| 83 | glucuronate metabolic process (GO:0019585) | 3.83350075 |
| 84 | uronic acid metabolic process (GO:0006063) | 3.83350075 |
| 85 | positive regulation of lipid catabolic process (GO:0050996) | 3.83097324 |
| 86 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.82583107 |
| 87 | flavonoid metabolic process (GO:0009812) | 3.81524990 |
| 88 | cofactor catabolic process (GO:0051187) | 3.81463821 |
| 89 | epoxygenase P450 pathway (GO:0019373) | 3.81397023 |
| 90 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.81200067 |
| 91 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.79779778 |
| 92 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.79779778 |
| 93 | cholesterol homeostasis (GO:0042632) | 3.79290435 |
| 94 | blood coagulation, intrinsic pathway (GO:0007597) | 3.77792004 |
| 95 | drug metabolic process (GO:0017144) | 3.76126047 |
| 96 | organic acid catabolic process (GO:0016054) | 3.74979904 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.74979904 |
| 98 | short-chain fatty acid metabolic process (GO:0046459) | 3.73839077 |
| 99 | sterol homeostasis (GO:0055092) | 3.72870387 |
| 100 | regulation of cholesterol homeostasis (GO:2000188) | 3.68140740 |
| 101 | plasma lipoprotein particle organization (GO:0071827) | 3.67754631 |
| 102 | phospholipid homeostasis (GO:0055091) | 3.65979845 |
| 103 | protein-lipid complex assembly (GO:0065005) | 3.64533498 |
| 104 | intestinal cholesterol absorption (GO:0030299) | 3.64523450 |
| 105 | protein activation cascade (GO:0072376) | 3.58634449 |
| 106 | acetyl-CoA metabolic process (GO:0006084) | 3.58625991 |
| 107 | L-methionine biosynthetic process (GO:0071265) | 3.55697927 |
| 108 | amino acid salvage (GO:0043102) | 3.55697927 |
| 109 | L-methionine salvage (GO:0071267) | 3.55697927 |
| 110 | behavioral response to nicotine (GO:0035095) | 3.52709190 |
| 111 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.39225748 |
| 112 | dopamine transport (GO:0015872) | 3.33412859 |
| 113 | regulation of glucokinase activity (GO:0033131) | 3.29198022 |
| 114 | regulation of hexokinase activity (GO:1903299) | 3.29198022 |
| 115 | protein K11-linked deubiquitination (GO:0035871) | 3.24431921 |
| 116 | arginine catabolic process (GO:0006527) | 3.17046783 |
| 117 | ethanol metabolic process (GO:0006067) | 3.14053026 |
| 118 | nucleobase catabolic process (GO:0046113) | 3.11462903 |
| 119 | negative regulation of telomere maintenance (GO:0032205) | 3.11035556 |
| 120 | heme transport (GO:0015886) | 3.05953974 |
| 121 | sulfation (GO:0051923) | 3.05573172 |
| 122 | indole-containing compound metabolic process (GO:0042430) | 3.03592777 |
| 123 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.00387029 |
| 124 | steroid catabolic process (GO:0006706) | 2.94699459 |
| 125 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.92942919 |
| 126 | detection of light stimulus involved in visual perception (GO:0050908) | 2.92942919 |
| 127 | peptidyl-glutamic acid modification (GO:0018200) | 2.90597545 |
| 128 | glycerophospholipid catabolic process (GO:0046475) | 2.86533928 |
| 129 | xenobiotic metabolic process (GO:0006805) | 2.82478268 |
| 130 | DNA deamination (GO:0045006) | 2.80534288 |
| 131 | positive regulation of fatty acid transport (GO:2000193) | 2.80327774 |
| 132 | organic cation transport (GO:0015695) | 2.78831604 |
| 133 | methionine biosynthetic process (GO:0009086) | 2.78749571 |
| 134 | protein complex biogenesis (GO:0070271) | 2.76137113 |
| 135 | drug transmembrane transport (GO:0006855) | 2.72606860 |
| 136 | vitamin biosynthetic process (GO:0009110) | 2.72039573 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.47450469 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.22454899 |
| 3 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.96344388 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.55556561 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.37638058 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 5.12923966 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.91292653 |
| 8 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 4.02402163 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.00348997 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.24981507 |
| 11 | ZNF274_21170338_ChIP-Seq_K562_Hela | 3.08175916 |
| 12 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.84384133 |
| 13 | VDR_22108803_ChIP-Seq_LS180_Human | 2.60809773 |
| 14 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.45866770 |
| 15 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.42493780 |
| 16 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.23155996 |
| 17 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07764349 |
| 18 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.03625420 |
| 19 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.8838362 |
| 20 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.99655089 |
| 21 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.99378844 |
| 22 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98506312 |
| 23 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.97159824 |
| 24 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.97088994 |
| 25 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.92098403 |
| 26 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.91076675 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.80049540 |
| 28 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.77151838 |
| 29 | P300_19829295_ChIP-Seq_ESCs_Human | 1.75076098 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.73098392 |
| 31 | EWS_26573619_Chip-Seq_HEK293_Human | 1.71583549 |
| 32 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.69733579 |
| 33 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.59016838 |
| 34 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.56005283 |
| 35 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.54121341 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53785905 |
| 37 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.53738122 |
| 38 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.53738122 |
| 39 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.52318594 |
| 40 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.52081638 |
| 41 | AR_25329375_ChIP-Seq_VCAP_Human | 1.50340764 |
| 42 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.49577917 |
| 43 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.49194196 |
| 44 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.46359117 |
| 45 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.45073149 |
| 46 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.44938351 |
| 47 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.42266052 |
| 48 | GATA1_22025678_ChIP-Seq_K562_Human | 1.41711493 |
| 49 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 1.40668088 |
| 50 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.39914642 |
| 51 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.39706240 |
| 52 | STAT3_23295773_ChIP-Seq_U87_Human | 1.39083846 |
| 53 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.38396782 |
| 54 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.38396782 |
| 55 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 1.38275102 |
| 56 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 1.38275102 |
| 57 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.37053559 |
| 58 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.35734332 |
| 59 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.35031400 |
| 60 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.35014685 |
| 61 | TCF4_23295773_ChIP-Seq_U87_Human | 1.34468647 |
| 62 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.34364958 |
| 63 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32517689 |
| 64 | GATA3_21878914_ChIP-Seq_MCF-7_Human | 1.31191379 |
| 65 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29412174 |
| 66 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.29247609 |
| 67 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.29135614 |
| 68 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28808394 |
| 69 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.28294984 |
| 70 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 1.25416360 |
| 71 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.24295499 |
| 72 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.23094503 |
| 73 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.21573954 |
| 74 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20003293 |
| 75 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19307421 |
| 76 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.19016275 |
| 77 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.18404276 |
| 78 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.18046952 |
| 79 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.17913932 |
| 80 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.17717646 |
| 81 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.17396522 |
| 82 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.14471465 |
| 83 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.14084209 |
| 84 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.13922469 |
| 85 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.12399763 |
| 86 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.10843332 |
| 87 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.10042272 |
| 88 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.09722091 |
| 89 | MYC_19829295_ChIP-Seq_ESCs_Human | 1.09432400 |
| 90 | PHF8_20622853_ChIP-Seq_HELA_Human | 1.08892255 |
| 91 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.08847240 |
| 92 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 1.08247116 |
| 93 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.07242258 |
| 94 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06679070 |
| 95 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05284411 |
| 96 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.04619348 |
| 97 | * OCT4_21477851_ChIP-Seq_ESCs_Mouse | 1.04476090 |
| 98 | ETV1_20927104_ChIP-Seq_GIST48_Human | 1.02385974 |
| 99 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.02131523 |
| 100 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.01554798 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.01554773 |
| 102 | ERA_21632823_ChIP-Seq_H3396_Human | 1.01283987 |
| 103 | HOXB7_26014856_ChIP-Seq_BT474_Human | 1.00612386 |
| 104 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.00468779 |
| 105 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96962505 |
| 106 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.96767552 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.93430099 |
| 108 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.87228399 |
| 109 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.86597653 |
| 110 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85164964 |
| 111 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.82702340 |
| 112 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.81294446 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.81273225 |
| 114 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.79026798 |
| 115 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78076582 |
| 116 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.77864627 |
| 117 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74336300 |
| 118 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.74118195 |
| 119 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73922906 |
| 120 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.71804744 |
| 121 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.69849995 |
| 122 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69324879 |
| 123 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 0.69309301 |
| 124 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.66141745 |
| 125 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.65595856 |
| 126 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.65543347 |
| 127 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.64672911 |
| 128 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.63713979 |
| 129 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.63008057 |
| 130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.62783790 |
| 131 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.62015780 |
| 132 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.61592140 |
| 133 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.61441318 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.60867059 |
| 135 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.60867059 |
| 136 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.58465580 |
| 137 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.56310526 |
| 138 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53052949 |
| 139 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.51506517 |
| 140 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.51426321 |
| 141 | AR_20517297_ChIP-Seq_VCAP_Human | 0.50798435 |
| 142 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.50141478 |
| 143 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.49594350 |
| 144 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.49140122 |
| 145 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.49126508 |
| 146 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.48976184 |
| 147 | CBP_21632823_ChIP-Seq_H3396_Human | 0.48563386 |
| 148 | FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.48354652 |
| 149 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.46623870 |
| 150 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.46187611 |
| 151 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.45748262 |
| 152 | * P53_21459846_ChIP-Seq_SAOS-2_Human | 0.44920147 |
| 153 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.44669515 |
| 154 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44069167 |
| 155 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.43980093 |
| 156 | GATA1_19941826_ChIP-Seq_K562_Human | 0.42583838 |
| 157 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.42359613 |
| 158 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.42146178 |
| 159 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40464599 |
| 160 | GATA2_19941826_ChIP-Seq_K562_Human | 0.39865867 |
| 161 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.39674551 |
| 162 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.39660705 |
| 163 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.39198655 |
| 164 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.39154551 |
| 165 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.38780128 |
| 166 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.38557963 |
| 167 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.38527159 |
| 168 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.38354245 |
| 169 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.37269211 |
| 170 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.36448259 |
| 171 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.36051181 |
| 172 | NCOR_22424771_ChIP-Seq_293T_Human | 0.35086339 |
| 173 | * SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.34375094 |
| 174 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.33962213 |
| 175 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.33528866 |
| 176 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.33144480 |
| 177 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.32742681 |
| 178 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.32705909 |
| 179 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.32596529 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.44355459 |
| 2 | MP0005360_urolithiasis | 7.53085305 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 6.50822230 |
| 4 | MP0005365_abnormal_bile_salt | 6.16067649 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 5.21768945 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.14503734 |
| 7 | MP0003252_abnormal_bile_duct | 3.94167479 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.60983339 |
| 9 | MP0009840_abnormal_foam_cell | 3.38189741 |
| 10 | MP0005083_abnormal_biliary_tract | 3.08815314 |
| 11 | MP0003195_calcinosis | 2.90097327 |
| 12 | MP0005332_abnormal_amino_acid | 2.77031662 |
| 13 | MP0001666_abnormal_nutrient_absorption | 2.65392490 |
| 14 | MP0003191_abnormal_cellular_cholesterol | 2.24650020 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.16801168 |
| 16 | * MP0000609_abnormal_liver_physiology | 2.13688777 |
| 17 | * MP0002118_abnormal_lipid_homeostasis | 2.09275601 |
| 18 | MP0005551_abnormal_eye_electrophysiolog | 1.98838502 |
| 19 | MP0008877_abnormal_DNA_methylation | 1.91894427 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 1.90299865 |
| 21 | MP0003868_abnormal_feces_composition | 1.88487973 |
| 22 | MP0005319_abnormal_enzyme/_coenzyme | 1.82886820 |
| 23 | MP0005646_abnormal_pituitary_gland | 1.75752309 |
| 24 | MP0002102_abnormal_ear_morphology | 1.75097790 |
| 25 | MP0001986_abnormal_taste_sensitivity | 1.74040909 |
| 26 | MP0001764_abnormal_homeostasis | 1.67054362 |
| 27 | MP0004043_abnormal_pH_regulation | 1.66106649 |
| 28 | MP0005451_abnormal_body_composition | 1.65030860 |
| 29 | MP0009745_abnormal_behavioral_response | 1.64355277 |
| 30 | MP0001968_abnormal_touch/_nociception | 1.64314976 |
| 31 | MP0005645_abnormal_hypothalamus_physiol | 1.61593401 |
| 32 | MP0009697_abnormal_copulation | 1.59210513 |
| 33 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56326530 |
| 34 | MP0001984_abnormal_olfaction | 1.46099581 |
| 35 | MP0004147_increased_porphyrin_level | 1.43624115 |
| 36 | MP0002163_abnormal_gland_morphology | 1.41071125 |
| 37 | MP0006072_abnormal_retinal_apoptosis | 1.37932908 |
| 38 | MP0009046_muscle_twitch | 1.36453484 |
| 39 | MP0004142_abnormal_muscle_tone | 1.35365457 |
| 40 | MP0002736_abnormal_nociception_after | 1.34728763 |
| 41 | MP0003787_abnormal_imprinting | 1.33111457 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.32831577 |
| 43 | MP0003011_delayed_dark_adaptation | 1.31811015 |
| 44 | MP0003656_abnormal_erythrocyte_physiolo | 1.29369195 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.28962843 |
| 46 | MP0005379_endocrine/exocrine_gland_phen | 1.28459868 |
| 47 | MP0002272_abnormal_nervous_system | 1.26893702 |
| 48 | MP0003880_abnormal_central_pattern | 1.24391201 |
| 49 | MP0009643_abnormal_urine_homeostasis | 1.21826515 |
| 50 | MP0003186_abnormal_redox_activity | 1.21341006 |
| 51 | MP0003646_muscle_fatigue | 1.18936365 |
| 52 | MP0004133_heterotaxia | 1.17763886 |
| 53 | MP0000598_abnormal_liver_morphology | 1.17336615 |
| 54 | MP0001501_abnormal_sleep_pattern | 1.12152272 |
| 55 | MP0002064_seizures | 1.11176743 |
| 56 | MP0005647_abnormal_sex_gland | 1.10530530 |
| 57 | MP0003705_abnormal_hypodermis_morpholog | 1.08029750 |
| 58 | MP0009764_decreased_sensitivity_to | 1.08014352 |
| 59 | MP0000604_amyloidosis | 1.07393048 |
| 60 | MP0005187_abnormal_penis_morphology | 1.07101727 |
| 61 | MP0005389_reproductive_system_phenotype | 1.06649162 |
| 62 | MP0004885_abnormal_endolymph | 1.05380415 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.04155612 |
| 64 | MP0005253_abnormal_eye_physiology | 1.04033047 |
| 65 | MP0001905_abnormal_dopamine_level | 1.02973231 |
| 66 | MP0001919_abnormal_reproductive_system | 1.01744350 |
| 67 | MP0009763_increased_sensitivity_to | 1.01250174 |
| 68 | MP0001486_abnormal_startle_reflex | 1.00286897 |
| 69 | MP0002254_reproductive_system_inflammat | 0.99572927 |
| 70 | MP0010386_abnormal_urinary_bladder | 0.97391244 |
| 71 | MP0000372_irregular_coat_pigmentation | 0.94871320 |
| 72 | MP0002160_abnormal_reproductive_system | 0.93427405 |
| 73 | MP0002572_abnormal_emotion/affect_behav | 0.93062089 |
| 74 | MP0000427_abnormal_hair_cycle | 0.91931763 |
| 75 | MP0000569_abnormal_digit_pigmentation | 0.90551409 |
| 76 | MP0010368_abnormal_lymphatic_system | 0.90345870 |
| 77 | MP0005377_hearing/vestibular/ear_phenot | 0.90193237 |
| 78 | MP0003878_abnormal_ear_physiology | 0.90193237 |
| 79 | MP0005636_abnormal_mineral_homeostasis | 0.89927596 |
| 80 | MP0008469_abnormal_protein_level | 0.86957287 |
| 81 | * MP0009642_abnormal_blood_homeostasis | 0.86426586 |
| 82 | MP0005670_abnormal_white_adipose | 0.86305838 |
| 83 | MP0002938_white_spotting | 0.86033348 |
| 84 | MP0002557_abnormal_social/conspecific_i | 0.85931463 |
| 85 | MP0004924_abnormal_behavior | 0.84973899 |
| 86 | MP0005386_behavior/neurological_phenoty | 0.84973899 |
| 87 | MP0000631_abnormal_neuroendocrine_gland | 0.83578314 |
| 88 | MP0006036_abnormal_mitochondrial_physio | 0.83514397 |
| 89 | MP0004145_abnormal_muscle_electrophysio | 0.82295884 |
| 90 | MP0005408_hypopigmentation | 0.81336947 |
| 91 | MP0009765_abnormal_xenobiotic_induced | 0.80671412 |
| 92 | MP0002234_abnormal_pharynx_morphology | 0.80080844 |
| 93 | MP0005376_homeostasis/metabolism_phenot | 0.78840434 |
| 94 | MP0002876_abnormal_thyroid_physiology | 0.77591055 |
| 95 | MP0005084_abnormal_gallbladder_morpholo | 0.77471228 |
| 96 | * MP0002078_abnormal_glucose_homeostasis | 0.75792773 |
| 97 | MP0002971_abnormal_brown_adipose | 0.74883901 |
| 98 | MP0004742_abnormal_vestibular_system | 0.72964240 |
| 99 | MP0001970_abnormal_pain_threshold | 0.72301584 |
| 100 | MP0005410_abnormal_fertilization | 0.70707710 |
| 101 | MP0005334_abnormal_fat_pad | 0.70565752 |
| 102 | MP0001485_abnormal_pinna_reflex | 0.70445742 |
| 103 | MP0005195_abnormal_posterior_eye | 0.70387220 |
| 104 | MP0004130_abnormal_muscle_cell | 0.69310636 |
| 105 | MP0003690_abnormal_glial_cell | 0.68585504 |
| 106 | MP0002733_abnormal_thermal_nociception | 0.68563505 |
| 107 | MP0002909_abnormal_adrenal_gland | 0.67973145 |
| 108 | MP0005535_abnormal_body_temperature | 0.67530441 |
| 109 | MP0002229_neurodegeneration | 0.67018942 |
| 110 | MP0005423_abnormal_somatic_nervous | 0.66986169 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.66447557 |
| 112 | MP0001661_extended_life_span | 0.66398768 |
| 113 | MP0005220_abnormal_exocrine_pancreas | 0.66035969 |
| 114 | MP0005266_abnormal_metabolism | 0.65352749 |
| 115 | MP0003329_amyloid_beta_deposits | 0.65056312 |
| 116 | MP0001529_abnormal_vocalization | 0.64349304 |
| 117 | MP0002822_catalepsy | 0.64241077 |
| 118 | MP0009053_abnormal_anal_canal | 0.63954819 |
| 119 | MP0002063_abnormal_learning/memory/cond | 0.63853052 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.63027768 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.62650208 |
| 122 | MP0000639_abnormal_adrenal_gland | 0.59679731 |
| 123 | MP0005448_abnormal_energy_balance | 0.58381395 |
| 124 | MP0001756_abnormal_urination | 0.58222097 |
| 125 | MP0006035_abnormal_mitochondrial_morpho | 0.55629090 |
| 126 | MP0005464_abnormal_platelet_physiology | 0.51825140 |
| 127 | MP0008872_abnormal_physiological_respon | 0.49419721 |
| 128 | MP0003718_maternal_effect | 0.48001247 |
| 129 | MP0004782_abnormal_surfactant_physiolog | 0.47307644 |
| 130 | MP0005395_other_phenotype | 0.47306307 |
| 131 | MP0002136_abnormal_kidney_physiology | 0.44865352 |
| 132 | MP0002837_dystrophic_cardiac_calcinosis | 0.43864988 |
| 133 | MP0002928_abnormal_bile_duct | 0.43659039 |
| 134 | MP0003436_decreased_susceptibility_to | 0.42336170 |
| 135 | * MP0008874_decreased_physiological_sensi | 0.41901622 |
| 136 | MP0005248_abnormal_Harderian_gland | 0.41535545 |
| 137 | MP0003724_increased_susceptibility_to | 0.41268761 |
| 138 | MP0005666_abnormal_adipose_tissue | 0.39467248 |
| 139 | * MP0003953_abnormal_hormone_level | 0.39119396 |
| 140 | MP0003075_altered_response_to | 0.38954691 |
| 141 | * MP0008873_increased_physiological_sensi | 0.37849991 |
| 142 | MP0009672_abnormal_birth_weight | 0.36591025 |
| 143 | MP0005166_decreased_susceptibility_to | 0.35186015 |
| 144 | MP0009115_abnormal_fat_cell | 0.34072829 |
| 145 | MP0000230_abnormal_systemic_arterial | 0.33141230 |
| 146 | MP0000249_abnormal_blood_vessel | 0.32727545 |
| 147 | MP0001243_abnormal_dermal_layer | 0.32591122 |
| 148 | * MP0003638_abnormal_response/metabolism_ | 0.32270399 |
| 149 | MP0001853_heart_inflammation | 0.32212953 |
| 150 | MP0006082_CNS_inflammation | 0.31826694 |
| 151 | MP0002970_abnormal_white_adipose | 0.30087544 |
| 152 | MP0002168_other_aberrant_phenotype | 0.29672543 |
| 153 | MP0004883_abnormal_blood_vessel | 0.29097004 |
| 154 | MP0000579_abnormal_nail_morphology | 0.28945681 |
| 155 | MP0002090_abnormal_vision | 0.27556250 |
| 156 | MP0002796_impaired_skin_barrier | 0.26875803 |
| 157 | MP0001881_abnormal_mammary_gland | 0.26292233 |
| 158 | MP0001845_abnormal_inflammatory_respons | 0.26219580 |
| 159 | MP0004381_abnormal_hair_follicle | 0.26159231 |
| 160 | MP0005167_abnormal_blood-brain_barrier | 0.24631459 |
| 161 | MP0009384_cardiac_valve_regurgitation | 0.23634112 |
| 162 | MP0002132_abnormal_respiratory_system | 0.22413288 |
| 163 | MP0002060_abnormal_skin_morphology | 0.21712642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.57811089 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.39329749 |
| 3 | Intrahepatic cholestasis (HP:0001406) | 7.12312119 |
| 4 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.75633612 |
| 5 | Hypobetalipoproteinemia (HP:0003563) | 6.56753575 |
| 6 | Prolonged partial thromboplastin time (HP:0003645) | 6.55798519 |
| 7 | Xanthomatosis (HP:0000991) | 6.31770480 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.78319916 |
| 9 | Hypolipoproteinemia (HP:0010981) | 4.86889978 |
| 10 | Complement deficiency (HP:0004431) | 4.86143368 |
| 11 | Joint hemorrhage (HP:0005261) | 4.76646238 |
| 12 | Hyperammonemia (HP:0001987) | 4.62648986 |
| 13 | Epidermoid cyst (HP:0200040) | 4.53310280 |
| 14 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.46111783 |
| 15 | Abnormality of methionine metabolism (HP:0010901) | 4.39691865 |
| 16 | Hyperglycinemia (HP:0002154) | 4.36113654 |
| 17 | Abnormality of the common coagulation pathway (HP:0010990) | 4.33457665 |
| 18 | Ketosis (HP:0001946) | 4.33147848 |
| 19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27986761 |
| 20 | Hypoalphalipoproteinemia (HP:0003233) | 4.25810396 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.19810539 |
| 22 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.17293745 |
| 23 | Fat malabsorption (HP:0002630) | 3.99360962 |
| 24 | Hyperglycinuria (HP:0003108) | 3.95564580 |
| 25 | Abnormality of glycine metabolism (HP:0010895) | 3.94076818 |
| 26 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.94076818 |
| 27 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.91401301 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.86781337 |
| 29 | Hypercholesterolemia (HP:0003124) | 3.77674451 |
| 30 | Conjugated hyperbilirubinemia (HP:0002908) | 3.74458756 |
| 31 | Congenital stationary night blindness (HP:0007642) | 3.72424704 |
| 32 | Abnormality of the intrinsic pathway (HP:0010989) | 3.68844551 |
| 33 | Abnormality of complement system (HP:0005339) | 3.54268883 |
| 34 | Pancreatic cysts (HP:0001737) | 3.46422835 |
| 35 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.40382322 |
| 36 | Hyperbilirubinemia (HP:0002904) | 3.38952190 |
| 37 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.36208328 |
| 38 | Pancreatic fibrosis (HP:0100732) | 3.25673987 |
| 39 | Delayed CNS myelination (HP:0002188) | 3.17018869 |
| 40 | True hermaphroditism (HP:0010459) | 3.14092711 |
| 41 | Abnormality of nucleobase metabolism (HP:0010932) | 3.10065793 |
| 42 | Abnormality of serum amino acid levels (HP:0003112) | 3.04417247 |
| 43 | Ketoacidosis (HP:0001993) | 3.03447708 |
| 44 | Molar tooth sign on MRI (HP:0002419) | 3.00441419 |
| 45 | Abnormality of midbrain morphology (HP:0002418) | 3.00441419 |
| 46 | Steatorrhea (HP:0002570) | 2.98706516 |
| 47 | Myocardial infarction (HP:0001658) | 2.97927898 |
| 48 | Bile duct proliferation (HP:0001408) | 2.96455320 |
| 49 | Abnormal biliary tract physiology (HP:0012439) | 2.96455320 |
| 50 | Hepatocellular carcinoma (HP:0001402) | 2.95081245 |
| 51 | Spontaneous abortion (HP:0005268) | 2.93527012 |
| 52 | Chronic hepatic failure (HP:0100626) | 2.90713801 |
| 53 | Hyperventilation (HP:0002883) | 2.87641404 |
| 54 | Nephronophthisis (HP:0000090) | 2.85313537 |
| 55 | Fair hair (HP:0002286) | 2.83075184 |
| 56 | Hypochromic microcytic anemia (HP:0004840) | 2.82586347 |
| 57 | Metabolic acidosis (HP:0001942) | 2.81155222 |
| 58 | Skin nodule (HP:0200036) | 2.80071837 |
| 59 | Abnormality of the renal cortex (HP:0011035) | 2.72108910 |
| 60 | Abnormality of purine metabolism (HP:0004352) | 2.69398040 |
| 61 | Vascular calcification (HP:0004934) | 2.67498736 |
| 62 | Lethargy (HP:0001254) | 2.63718188 |
| 63 | Glycosuria (HP:0003076) | 2.62951127 |
| 64 | Abnormality of urine glucose concentration (HP:0011016) | 2.62951127 |
| 65 | Dicarboxylic aciduria (HP:0003215) | 2.62084665 |
| 66 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.62084665 |
| 67 | Attenuation of retinal blood vessels (HP:0007843) | 2.61324727 |
| 68 | Acute encephalopathy (HP:0006846) | 2.54124316 |
| 69 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.53322146 |
| 70 | Systemic lupus erythematosus (HP:0002725) | 2.53108776 |
| 71 | Acanthocytosis (HP:0001927) | 2.51754464 |
| 72 | Abolished electroretinogram (ERG) (HP:0000550) | 2.50676313 |
| 73 | Mitral stenosis (HP:0001718) | 2.49924509 |
| 74 | Abnormality of the renal medulla (HP:0100957) | 2.49124484 |
| 75 | Spastic diplegia (HP:0001264) | 2.47958694 |
| 76 | Abnormal gallbladder morphology (HP:0012437) | 2.47286647 |
| 77 | Cerebral edema (HP:0002181) | 2.47232423 |
| 78 | Hypoglycemic seizures (HP:0002173) | 2.46715194 |
| 79 | Glomerulonephritis (HP:0000099) | 2.43985202 |
| 80 | Mitochondrial inheritance (HP:0001427) | 2.43300697 |
| 81 | Increased CSF lactate (HP:0002490) | 2.42919138 |
| 82 | Cholelithiasis (HP:0001081) | 2.41355082 |
| 83 | Gout (HP:0001997) | 2.39553995 |
| 84 | Cardiovascular calcification (HP:0011915) | 2.36937851 |
| 85 | Irritability (HP:0000737) | 2.36704550 |
| 86 | Hepatic necrosis (HP:0002605) | 2.35030054 |
| 87 | Malnutrition (HP:0004395) | 2.33612584 |
| 88 | Hepatocellular necrosis (HP:0001404) | 2.32295844 |
| 89 | Abnormal drinking behavior (HP:0030082) | 2.32060197 |
| 90 | Polydipsia (HP:0001959) | 2.32060197 |
| 91 | Abnormal gallbladder physiology (HP:0012438) | 2.30777918 |
| 92 | Cholecystitis (HP:0001082) | 2.30777918 |
| 93 | Neonatal onset (HP:0003623) | 2.28686310 |
| 94 | Acute necrotizing encephalopathy (HP:0006965) | 2.27904047 |
| 95 | Congenital sensorineural hearing impairment (HP:0008527) | 2.27262920 |
| 96 | Amyloidosis (HP:0011034) | 2.25893463 |
| 97 | Hypothermia (HP:0002045) | 2.25594524 |
| 98 | Decreased central vision (HP:0007663) | 2.25111663 |
| 99 | Brushfield spots (HP:0001088) | 2.22641860 |
| 100 | Hyperalaninemia (HP:0003348) | 2.21113960 |
| 101 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.21113960 |
| 102 | Abnormality of alanine metabolism (HP:0010916) | 2.21113960 |
| 103 | Lipid accumulation in hepatocytes (HP:0006561) | 2.19907924 |
| 104 | Menorrhagia (HP:0000132) | 2.17786590 |
| 105 | Generalized hypopigmentation of hair (HP:0011358) | 2.17226655 |
| 106 | Type II lissencephaly (HP:0007260) | 2.17205858 |
| 107 | Late onset (HP:0003584) | 2.17179750 |
| 108 | Cystic liver disease (HP:0006706) | 2.15846757 |
| 109 | Esophageal varix (HP:0002040) | 2.15671621 |
| 110 | Gingival bleeding (HP:0000225) | 2.14834367 |
| 111 | Progressive macrocephaly (HP:0004481) | 2.10499894 |
| 112 | Pancreatitis (HP:0001733) | 2.10213093 |
| 113 | Poikilocytosis (HP:0004447) | 2.09816173 |
| 114 | Enlarged kidneys (HP:0000105) | 2.09696596 |
| 115 | Vomiting (HP:0002013) | 2.09665926 |
| 116 | Opisthotonus (HP:0002179) | 2.08129041 |
| 117 | Sensorimotor neuropathy (HP:0007141) | 2.07079191 |
| 118 | Thrombophlebitis (HP:0004418) | 2.04109783 |
| 119 | Generalized aminoaciduria (HP:0002909) | 2.03912197 |
| 120 | Hemorrhage of the eye (HP:0011885) | 2.03885461 |
| 121 | Methylmalonic acidemia (HP:0002912) | 2.02744155 |
| 122 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01685493 |
| 123 | Decreased circulating renin level (HP:0003351) | 2.01620143 |
| 124 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.99726064 |
| 125 | Pendular nystagmus (HP:0012043) | 1.99021853 |
| 126 | Abnormality of the gallbladder (HP:0005264) | 1.98606797 |
| 127 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.98535372 |
| 128 | Tubular atrophy (HP:0000092) | 1.97722524 |
| 129 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.97350561 |
| 130 | Hypophosphatemic rickets (HP:0004912) | 1.96592179 |
| 131 | Polyuria (HP:0000103) | 1.95317806 |
| 132 | Hydroxyprolinuria (HP:0003080) | 1.94203091 |
| 133 | Abnormality of proline metabolism (HP:0010907) | 1.94203091 |
| 134 | Medial flaring of the eyebrow (HP:0010747) | 1.94059944 |
| 135 | Male pseudohermaphroditism (HP:0000037) | 1.93898923 |
| 136 | Rickets (HP:0002748) | 1.93773662 |
| 137 | Abnormality of iron homeostasis (HP:0011031) | 1.92403637 |
| 138 | Large for gestational age (HP:0001520) | 1.91353584 |
| 139 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.88977608 |
| 140 | Increased serum lactate (HP:0002151) | 1.86873336 |
| 141 | Abnormal cartilage morphology (HP:0002763) | 1.86373910 |
| 142 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.86354382 |
| 143 | Renal cortical cysts (HP:0000803) | 1.86318364 |
| 144 | Status epilepticus (HP:0002133) | 1.86107674 |
| 145 | Arthropathy (HP:0003040) | 1.86009810 |
| 146 | Reduced antithrombin III activity (HP:0001976) | 1.85790636 |
| 147 | Limb dystonia (HP:0002451) | 1.85554713 |
| 148 | Abnormal urine output (HP:0012590) | 1.85507907 |
| 149 | Sclerocornea (HP:0000647) | 1.83581492 |
| 150 | Reticulocytosis (HP:0001923) | 1.81785149 |
| 151 | Alkalosis (HP:0001948) | 1.81516637 |
| 152 | Elevated hepatic transaminases (HP:0002910) | 1.80229608 |
| 153 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.80050302 |
| 154 | CNS demyelination (HP:0007305) | 1.78190591 |
| 155 | Increased hepatocellular lipid droplets (HP:0006565) | 1.78142747 |
| 156 | Renal Fanconi syndrome (HP:0001994) | 1.76211840 |
| 157 | Abnormality of vitamin metabolism (HP:0100508) | 1.76118346 |
| 158 | 3-Methylglutaconic aciduria (HP:0003535) | 1.75583665 |
| 159 | Hyperglycemia (HP:0003074) | 1.75520051 |
| 160 | Hyperphosphaturia (HP:0003109) | 1.75374956 |
| 161 | Nephritis (HP:0000123) | 1.73800458 |
| 162 | Broad-based gait (HP:0002136) | 1.73705257 |
| 163 | Optic disc pallor (HP:0000543) | 1.73642749 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 7.31276980 |
| 2 | SIK1 | 4.75062393 |
| 3 | FGFR4 | 4.61273345 |
| 4 | ERN1 | 4.16610599 |
| 5 | MAP4K2 | 3.26413308 |
| 6 | WNK3 | 3.14248841 |
| 7 | TLK1 | 3.07402126 |
| 8 | TAOK3 | 3.05094858 |
| 9 | INSRR | 3.04711133 |
| 10 | ADRBK2 | 3.02079124 |
| 11 | ERBB4 | 2.60196415 |
| 12 | ZAK | 2.47655483 |
| 13 | PKN2 | 2.47173564 |
| 14 | MAP2K4 | 2.43145391 |
| 15 | CASK | 2.37526004 |
| 16 | NUAK1 | 2.34823461 |
| 17 | MST1R | 2.18086827 |
| 18 | WNK4 | 2.06843949 |
| 19 | FLT3 | 2.02994828 |
| 20 | BMPR1B | 1.89335547 |
| 21 | PIK3CG | 1.81225474 |
| 22 | TRIB3 | 1.75485899 |
| 23 | TXK | 1.75463490 |
| 24 | MAPK11 | 1.73577968 |
| 25 | OXSR1 | 1.72092145 |
| 26 | TYK2 | 1.68751158 |
| 27 | MAPK13 | 1.60565244 |
| 28 | DAPK2 | 1.60434002 |
| 29 | ABL2 | 1.48332187 |
| 30 | PTK6 | 1.47868292 |
| 31 | LATS1 | 1.46946627 |
| 32 | FRK | 1.40041558 |
| 33 | FGFR2 | 1.39848842 |
| 34 | KDR | 1.38541332 |
| 35 | STK39 | 1.38411521 |
| 36 | MST4 | 1.37529339 |
| 37 | DYRK2 | 1.33387631 |
| 38 | TNIK | 1.32464048 |
| 39 | NTRK3 | 1.29396719 |
| 40 | PAK3 | 1.24236571 |
| 41 | NEK9 | 1.23019507 |
| 42 | JAK2 | 1.20286089 |
| 43 | MAP3K7 | 1.17625200 |
| 44 | PRKAA2 | 1.15583379 |
| 45 | GRK6 | 1.15004234 |
| 46 | PINK1 | 1.14074841 |
| 47 | ACVR1B | 1.12529979 |
| 48 | PHKG1 | 1.12187398 |
| 49 | PHKG2 | 1.12187398 |
| 50 | MAP3K4 | 1.12070550 |
| 51 | MAP2K3 | 1.11288534 |
| 52 | TRIM28 | 1.10817117 |
| 53 | TBK1 | 1.09046636 |
| 54 | MAPK4 | 1.03972516 |
| 55 | MAP3K14 | 0.99507768 |
| 56 | MAPKAPK3 | 0.98677136 |
| 57 | JAK1 | 0.98316710 |
| 58 | PRKCZ | 0.96345699 |
| 59 | ERBB2 | 0.96268675 |
| 60 | MAP3K10 | 0.93660996 |
| 61 | MAPK15 | 0.93208920 |
| 62 | PRKCE | 0.93157573 |
| 63 | ADRBK1 | 0.89409859 |
| 64 | NME1 | 0.88181431 |
| 65 | MAP3K11 | 0.87500206 |
| 66 | PLK2 | 0.87479404 |
| 67 | CAMKK2 | 0.86660310 |
| 68 | EIF2AK3 | 0.86639584 |
| 69 | MAPK12 | 0.86179288 |
| 70 | TAF1 | 0.84506733 |
| 71 | CSK | 0.83252907 |
| 72 | MAP3K3 | 0.82650774 |
| 73 | EPHB1 | 0.82401122 |
| 74 | MET | 0.81847904 |
| 75 | CDK6 | 0.80888494 |
| 76 | MAP2K6 | 0.80330262 |
| 77 | MAPKAPK5 | 0.80257098 |
| 78 | STK16 | 0.77047446 |
| 79 | STK38L | 0.76668837 |
| 80 | PRKACG | 0.75617263 |
| 81 | DYRK1B | 0.75408360 |
| 82 | TIE1 | 0.74337071 |
| 83 | VRK1 | 0.74161420 |
| 84 | EPHA4 | 0.72161939 |
| 85 | IKBKB | 0.69056110 |
| 86 | IRAK3 | 0.68921647 |
| 87 | SIK2 | 0.68514855 |
| 88 | CAMK2G | 0.66913978 |
| 89 | EPHA3 | 0.66427897 |
| 90 | MAP2K7 | 0.66093284 |
| 91 | MKNK2 | 0.65577839 |
| 92 | GSK3A | 0.64738514 |
| 93 | VRK2 | 0.63787237 |
| 94 | SGK3 | 0.63581864 |
| 95 | PRKAA1 | 0.63460493 |
| 96 | MARK1 | 0.62558536 |
| 97 | BCR | 0.61394045 |
| 98 | MAPK7 | 0.60339169 |
| 99 | GRK7 | 0.59470546 |
| 100 | PRKACA | 0.59174034 |
| 101 | PRKCI | 0.58985419 |
| 102 | CSNK1A1 | 0.57408613 |
| 103 | CAMK1D | 0.56738049 |
| 104 | ERBB3 | 0.56470761 |
| 105 | BRSK2 | 0.56277939 |
| 106 | TGFBR2 | 0.55619270 |
| 107 | TAOK2 | 0.55591142 |
| 108 | PRKG1 | 0.55513234 |
| 109 | MUSK | 0.55463482 |
| 110 | STK11 | 0.55120537 |
| 111 | PTK2 | 0.54938218 |
| 112 | RIPK1 | 0.54241512 |
| 113 | IKBKE | 0.54073041 |
| 114 | PRKCQ | 0.53752405 |
| 115 | PTK2B | 0.53175795 |
| 116 | CSF1R | 0.52496579 |
| 117 | PLK4 | 0.52200378 |
| 118 | PDPK1 | 0.51839005 |
| 119 | FGFR3 | 0.51769810 |
| 120 | CSNK1G1 | 0.50566346 |
| 121 | FER | 0.48904531 |
| 122 | CAMK2A | 0.48305605 |
| 123 | MAP3K5 | 0.47215887 |
| 124 | SGK2 | 0.45422294 |
| 125 | PLK3 | 0.44832503 |
| 126 | GRK1 | 0.44825185 |
| 127 | CAMK1 | 0.44647773 |
| 128 | IGF1R | 0.43951119 |
| 129 | GRK5 | 0.43503093 |
| 130 | CSNK1D | 0.42518492 |
| 131 | TRPM7 | 0.42473788 |
| 132 | RET | 0.42144037 |
| 133 | CDK4 | 0.41988413 |
| 134 | KIT | 0.41867654 |
| 135 | STK3 | 0.41671700 |
| 136 | EIF2AK2 | 0.41508077 |
| 137 | PNCK | 0.40941504 |
| 138 | PRKCG | 0.40864000 |
| 139 | RPS6KA5 | 0.39071126 |
| 140 | MAP3K13 | 0.38767033 |
| 141 | MAP2K1 | 0.37797504 |
| 142 | MAP3K6 | 0.37299239 |
| 143 | WEE1 | 0.36747016 |
| 144 | ICK | 0.35439173 |
| 145 | OBSCN | 0.33930469 |
| 146 | PBK | 0.33236230 |
| 147 | AKT3 | 0.33130851 |
| 148 | CAMK4 | 0.33000597 |
| 149 | MAP3K12 | 0.32812081 |
| 150 | MINK1 | 0.32601600 |
| 151 | MTOR | 0.32022141 |
| 152 | PDK1 | 0.31965756 |
| 153 | CAMK2D | 0.31282860 |
| 154 | CHUK | 0.31278057 |
| 155 | CSNK1G2 | 0.30636683 |
| 156 | SGK494 | 0.29767146 |
| 157 | SGK223 | 0.29767146 |
| 158 | IRAK2 | 0.28834097 |
| 159 | EGFR | 0.28642496 |
| 160 | PIK3CA | 0.28125545 |
| 161 | PKN1 | 0.28089359 |
| 162 | MAP3K1 | 0.26967244 |
| 163 | CSNK1G3 | 0.26788610 |
| 164 | IRAK1 | 0.24326534 |
| 165 | * PRKCA | 0.22970353 |
| 166 | MAP2K2 | 0.22727152 |
| 167 | PDK3 | 0.20695680 |
| 168 | PDK4 | 0.20695680 |
| 169 | LATS2 | 0.19724273 |
| 170 | CSNK1A1L | 0.19360108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.43243272 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.48657069 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.44900725 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.33563919 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.04769923 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.77528339 |
| 7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71402549 |
| 8 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.63614005 |
| 9 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.56994411 |
| 10 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.49511314 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.48278730 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.36503870 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.33738738 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.23102664 |
| 15 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.14521973 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.06172977 |
| 17 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.03691583 |
| 18 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 2.02715278 |
| 19 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.02016041 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.98124208 |
| 21 | Histidine metabolism_Homo sapiens_hsa00340 | 1.93779205 |
| 22 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.89176847 |
| 23 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.88244052 |
| 24 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.83945683 |
| 25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.77995258 |
| 26 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.77488578 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.72734194 |
| 28 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.72140367 |
| 29 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.71517285 |
| 30 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.71259044 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.60693456 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56535442 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55275401 |
| 34 | Bile secretion_Homo sapiens_hsa04976 | 1.53488671 |
| 35 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.50978134 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.50433087 |
| 37 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.41624039 |
| 38 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.39472286 |
| 39 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.35075130 |
| 40 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.32782982 |
| 41 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.32212975 |
| 42 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30771594 |
| 43 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.30045743 |
| 44 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23964906 |
| 45 | Phototransduction_Homo sapiens_hsa04744 | 1.22829564 |
| 46 | ABC transporters_Homo sapiens_hsa02010 | 1.22584537 |
| 47 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.20032238 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17931217 |
| 49 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.15648152 |
| 50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.09376502 |
| 51 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.07569731 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.03161556 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.00841453 |
| 54 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.00410438 |
| 55 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.99320044 |
| 56 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98806779 |
| 57 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.98804604 |
| 58 | Parkinsons disease_Homo sapiens_hsa05012 | 0.98687142 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94851489 |
| 60 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.88334675 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.85977131 |
| 62 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.85334734 |
| 63 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.84478929 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.82171132 |
| 65 | Lysine degradation_Homo sapiens_hsa00310 | 0.81552056 |
| 66 | Nicotine addiction_Homo sapiens_hsa05033 | 0.78960005 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75169021 |
| 68 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.68934543 |
| 69 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.68723508 |
| 70 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.68672374 |
| 71 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.67762553 |
| 72 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.67229376 |
| 73 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.65855892 |
| 74 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.62749982 |
| 75 | Homologous recombination_Homo sapiens_hsa03440 | 0.62192313 |
| 76 | RNA polymerase_Homo sapiens_hsa03020 | 0.54381249 |
| 77 | Alzheimers disease_Homo sapiens_hsa05010 | 0.54203070 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.54121116 |
| 79 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.49417353 |
| 80 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.47878747 |
| 81 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.46588596 |
| 82 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46145364 |
| 83 | Huntingtons disease_Homo sapiens_hsa05016 | 0.45810577 |
| 84 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.45100895 |
| 85 | Basal transcription factors_Homo sapiens_hsa03022 | 0.41364394 |
| 86 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.39018972 |
| 87 | Proteasome_Homo sapiens_hsa03050 | 0.37202211 |
| 88 | Morphine addiction_Homo sapiens_hsa05032 | 0.35894880 |
| 89 | GABAergic synapse_Homo sapiens_hsa04727 | 0.34955127 |
| 90 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.34479007 |
| 91 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.34365659 |
| 92 | Taste transduction_Homo sapiens_hsa04742 | 0.34084121 |
| 93 | Insulin secretion_Homo sapiens_hsa04911 | 0.33306929 |
| 94 | Mineral absorption_Homo sapiens_hsa04978 | 0.31868779 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.31174319 |
| 96 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.28737232 |
| 97 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26298937 |
| 98 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.25678723 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.23255792 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22871135 |
| 101 | Prion diseases_Homo sapiens_hsa05020 | 0.22637926 |
| 102 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21188399 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.20689828 |
| 104 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.19941184 |
| 105 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.17029653 |
| 106 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.16857427 |
| 107 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.15992051 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.10133210 |
| 109 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.02296118 |
| 110 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | -0.2580210 |
| 111 | Ether lipid metabolism_Homo sapiens_hsa00565 | -0.2511593 |
| 112 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | -0.2457508 |
| 113 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2446916 |
| 114 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | -0.2414509 |
| 115 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1977919 |
| 116 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.1976991 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | -0.1941170 |
| 118 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | -0.1919829 |
| 119 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.1744567 |
| 120 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1666402 |
| 121 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1656379 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1583214 |
| 123 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.1521600 |
| 124 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1487395 |
| 125 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1385442 |
| 126 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1077024 |
| 127 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1075818 |
| 128 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0939364 |
| 129 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0555047 |
| 130 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0096501 |

